XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 27, 2025
Sep. 28, 2024
Sep. 27, 2025
Sep. 28, 2024
Income Statement [Abstract]        
Net sales $ 342,879 $ 426,617 $ 1,064,065 $ 1,305,479
Cost of sales 137,490 167,089 424,396 528,287
Gross profit 205,389 259,528 639,669 777,192
Operating expenses:        
Sales and marketing 167,430 205,480 502,997 596,392
General and administrative 31,792 33,070 100,015 111,722
Research and development 7,328 10,583 27,651 34,602
Restructuring costs 39,154 1,963 47,546 14,382
Total operating expenses 245,704 251,096 678,209 757,098
Operating (loss) income (40,315) 8,432 (38,540) 20,094
Interest expense, net 12,687 12,057 35,502 36,626
Loss before income taxes (53,002) (3,625) (74,042) (16,532)
Income tax benefit (13,212) (489) (594) (863)
Net loss $ (39,790) $ (3,136) $ (73,448) $ (15,669)
Basic net loss per share:        
Net loss per share – basic (in dollars per share) $ (1.73) $ (0.14) $ (3.21) $ (0.69)
Weighted-average shares – basic (in shares) 22,964 22,643 22,858 22,588
Diluted net loss per share:        
Net loss per share – diluted (in dollars per share) $ (1.73) $ (0.14) $ (3.21) $ (0.69)
Weighted-average shares – diluted (in shares) 22,964 22,643 22,858 22,588